Your browser doesn't support javascript.
loading
GlnH, a Novel Antigen That Offers Partial Protection against Verocytotoxigenic Escherichia coli Infection.
Quinn, Conor; Tomás-Cortázar, Julen; Ofioritse, Oritsejolomi; Cosgrave, Joanne; Purcell, Claire; McAloon, Catherine; Frost, Susanna; McClean, Siobhán.
Affiliation
  • Quinn C; School of Biomolecular and Biomedical Sciences, University College Dublin, Belfield, Dublin 4, Ireland.
  • Tomás-Cortázar J; UCD Conway Institute, University College Dublin, Belfield, Dublin 24, Ireland.
  • Ofioritse O; APC Ltd., Building 11, Cherrywood Business Park, Loughlinstown, D18 DH5 Co. Dublin, Ireland.
  • Cosgrave J; School of Biomolecular and Biomedical Sciences, University College Dublin, Belfield, Dublin 4, Ireland.
  • Purcell C; UCD Conway Institute, University College Dublin, Belfield, Dublin 24, Ireland.
  • McAloon C; School of Biomolecular and Biomedical Sciences, University College Dublin, Belfield, Dublin 4, Ireland.
  • Frost S; School of Biomolecular and Biomedical Sciences, University College Dublin, Belfield, Dublin 4, Ireland.
  • McClean S; Children's Health Ireland (CHI) at Tallaght, Tallaght University Hospital, Tallaght, Dublin 24, Ireland.
Vaccines (Basel) ; 11(1)2023 Jan 13.
Article de En | MEDLINE | ID: mdl-36680019

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Vaccines (Basel) Année: 2023 Type de document: Article Pays d'affiliation: Irlande

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Vaccines (Basel) Année: 2023 Type de document: Article Pays d'affiliation: Irlande